In a major breakthrough several years ago, two research groups, the Zuker group at Columbia and the Bachmanov group at the Monell Center for Chemical Senses, each got around this problem by finding drugs that could temporarily block a certain type
of sodium channel in mice's mouths.
The researchers found that, in mice lacking the fragile X protein, mGluR5 provides a signal to modify a
kind of sodium channel so that such channels persistently allow too much sodium to flow into neurons.
«However, this did not reveal any increased formation
of sodium channel proteins, which could have explained the overexcitation of nerve cells.»
Small changes in the protein
sequence of sodium channels of American compared with German cockroaches leave the latter susceptible to a venom that has little effect on the former.
They found that, as with calcium channels, increasing calcium concentrations caused calmodulin to bind within the resemblance
element of sodium channels and prevent their opening, just as in calcium channels.
The picture for sodium channels, however, was muddier, with different researchers reporting conflicting findings about whether calmodulin and the resemblance element prevent the
opening of sodium channels; perhaps the time capsule was damaged over the millenia or was never there.
One very exciting possibility is that the
cross-linking of sodium channel α - subunits by 3 trimers could lead to several sodium channels being functionally connected together.
Miljanich believes that a viable alternative to opioids that could work against all pain syndromes could arrive in the next three to four years, most likely as some
sort of sodium channel 1.7 blocker.
Intrigued, the doctor, a geneticist named Geoffrey Woods, eventually discovered two families who carried a genetic mutation that blocked the
functioning of sodium channel 1.7.
Fridman and Guan realized that the pain and «feeling» sensory neurons each contained different
kinds of sodium channels and that it may be possible to block one kind of channel and not the others to prevent patients from feeling pain but not other sensations.
New Cambridge research provides fresh and unexpected insight into the
structure of sodium channels and, specifically, one of its components — β - subunit molecules — which are responsible for «fine - tuning» the activity of the channel.
They want to find something — an engineered small molecule, antibody or, in King's case, a peptide isolated from venom — that inhibits the functioning
of sodium channel 1.7.